Compound Specifications CAS 221231-10-3 MW 1815.08 g/mol Formula C78H125N23O23S1 Purity 99% (HPLC) Documentation & Lab Use Form: Lyophilized research material Documentation: Review the product label, batch records, and applicable laboratory SOPs before accessioning
[Crossref] 10
(From Feid C, Presentation at the American College of Phlebology Sclerotherapy Workshop, Atlanta, Ga., November 2000.) Detergent sclerosing agents have been studied regarding their direct toxic effects on the formed elements of blood
The low computational demands and the robustness of rFASTCORMICS allowed the reconstruction of thousands of sample models that allow assessing how many patients share a metabolic alteration that can be exploited as drug target and hence allow us to identify metabolic rewiring strategies that are common across cancer patients and more particularly across melanoma patients
Astrocytes are active players in cerebral innate immunity
Sikorska et al., 2008), we raise the following questions: (i) does the observed methylation of Sox2 in astrocytes also occur in aged stem cells and would it decrease their ability to differentiate and give rise to new neurons
